Lessons and pitfalls from the 2020 Gout Clinical Practice Guideline presented in Atlanta at the ACR 2019

Area of Science:

• Rheumatology
• Immunology
• Metabolic Diseases

Background:

• Gout is the most prevalent form of arthritis, characterized by inflammasome activation due to monosodium urate crystals.
• It is associated with metabolic dysregulation leading to hyperuricemia and urate crystal deposition.
• Despite being curable, gout management is often suboptimal, necessitating updated clinical guidance.

Purpose of the Study:

• To review and disseminate recent updates to the American College of Rheumatology (ACR) quality guidelines for gout management.
• To highlight the strong and conditional recommendations within the updated guideline.
• To inform physicians and rheumatologists globally about advancements in gout care.

Main Methods:

• Review of the latest published American College of Rheumatology (ACR) guidelines for gout management.
• Analysis of the specific recommendations, categorizing them as strong or conditional.
• Synthesis of key updates relevant to clinical practice.

Main Results:

• The ACR has released updated guidelines for gout management.
• These guidelines include both strong recommendations, indicating high certainty of benefit, and conditional recommendations, requiring consideration of individual patient values and circumstances.
• The updates aim to address the suboptimal treatment outcomes observed in many gout patients.

Conclusions:

• Adherence to updated clinical guidelines is crucial for improving gout patient outcomes.
• Understanding the nuances of strong versus conditional recommendations allows for tailored patient care.
• Global adoption of evidence-based recommendations can enhance the quality of care for gout worldwide.